Back to search

Article

The impact of methylarginine metabolism on disease progression in idiopathic pulmonary fibrosis

2018-01-01

Abstract excerpt

Idiopathic pulmonary fibrosis (IPF) is a complex, progressive and irreversible lung disease of unknown aetiology with a median survival of only three years following diagnosis. Signatures of increased nitric oxide (NO) and its generating enzyme, inducible nitric oxide synthase (iNOS), are observed in experimental models of idiopathic pulmonary fibrosis (IPF). Asymmetric dimethylarginine (ADMA) competitively inhibi...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
a3678e7e-d7f7-59fc-868e-f73ab92265a5
DOI
10.25560/80431
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
The impact of methylarginine metabolism on disease progression in idiopathic pulmonary fibrosisDOI 10.25560/80431
Select a neighboring publication to make it the new centre.